fda tirzepatide approval for Zepbound: FSU researcher available for context on newly approved weight loss treatment Zepbound's New FDA Approval: What

These can present as: Urticaria (hives) raised, itchy wheals that may appear anywhere on the body Maculopapular rash flat or slightly raised red spots, sometimes with small bumps Generalised pruritus without visible rash In rare instances, patients may develop angioedema (swelling of deeper skin layers, particularly around the face, lips, or throat) or anaphylaxis , which requires immediate medical attention and discontinuation of treatment

Eur.Urol

We know obesity is multi factorial, while patients are on these medications it very important to address the other issues as in teaching proper dietary habits, increasing physical activity and improving sleep hygiene

It is particularly beneficial for those with weight-related conditions like type 2 diabetes or high cholesterol

The selenoproteome exhibits widely varying, tissue-specific dependence on selenoprotein P for selenium supply

The role of oxidative stress in skeletal muscle injury and regeneration: focus on antioxidant enzymes